BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 36867384)

  • 1. Prophylactic Efficacy and Safety of Antithrombotic Regimens in Patients with Stable Atherosclerotic Cardiovascular Disease (S-ASCVD): A Bayesian Network Meta-Regression Analysis.
    Zheng N; Zhong J; Chen X; Su J; Liu C; Jiang L
    Am J Cardiovasc Drugs; 2023 May; 23(3):257-267. PubMed ID: 36867384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis.
    Willems LH; Maas DPMSM; Kramers K; Reijnen MMPJ; Riksen NP; Ten Cate H; van der Vijver-Coppen RJ; de Borst GJ; Mees BME; Zeebregts CJ; Hannink G; Warlé MC
    Drugs; 2022 Aug; 82(12):1287-1302. PubMed ID: 35997941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Different Chronic Maintenance Antithrombotic Strategies in Patients with Coronary Artery Disease: A Systematic Review and Network Meta-Analysis.
    Zhang J; Chen Z; Cai Y; Li C; He Y
    Cardiovasc Ther; 2023; 2023():5446271. PubMed ID: 37636560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison efficacy and safety of different antiplatelet or anticoagulation drugs in chronic coronary syndromes patients: A Bayesian network meta-analysis.
    Liu C; Ma L
    Medicine (Baltimore); 2023 Dec; 102(48):e36429. PubMed ID: 38050293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC).
    Navarese EP; Landi A; Oliva A; Piccolo R; Aboyans V; Angiolillo D; Atar D; Capodanno D; Fox KAA; Halvorsen S; James S; Jüni P; Kunadian V; Leonardi S; Mehran R; Montalescot G; Niebauer J; Price S; Storey RF; Völler H; Vranckx P; Windecker S; Valgimigli M
    Eur Heart J Cardiovasc Pharmacother; 2023 Apr; 9(3):271-290. PubMed ID: 36869784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
    Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM
    Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Long-Term Antithrombotic Strategies in Patients With Chronic Coronary Syndrome: A Network Meta-analysis of Randomized Controlled Trials.
    Zhu H; Xu X; Fang X; Ying F; Song L; Gao B; Tong G; Zhou L; Chen T; Huang J
    J Am Heart Assoc; 2021 Mar; 10(6):e019184. PubMed ID: 33682435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Anand SS; Bosch J; Eikelboom JW; Connolly SJ; Diaz R; Widimsky P; Aboyans V; Alings M; Kakkar AK; Keltai K; Maggioni AP; Lewis BS; Störk S; Zhu J; Lopez-Jaramillo P; O'Donnell M; Commerford PJ; Vinereanu D; Pogosova N; Ryden L; Fox KAA; Bhatt DL; Misselwitz F; Varigos JD; Vanassche T; Avezum AA; Chen E; Branch K; Leong DP; Bangdiwala SI; Hart RG; Yusuf S;
    Lancet; 2018 Jan; 391(10117):219-229. PubMed ID: 29132880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Ticagrelor versus Aspirin and Clopidogrel for Stroke Prevention in Patients with Vascular Disease: A Systematic Review and Meta-Analysis.
    Ma X; Li D; Liu S; Chen Y; Zhong P
    Eur Neurol; 2023; 86(4):229-241. PubMed ID: 37068471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
    Eikelboom JW; Connolly SJ; Bosch J; Dagenais GR; Hart RG; Shestakovska O; Diaz R; Alings M; Lonn EM; Anand SS; Widimsky P; Hori M; Avezum A; Piegas LS; Branch KRH; Probstfield J; Bhatt DL; Zhu J; Liang Y; Maggioni AP; Lopez-Jaramillo P; O'Donnell M; Kakkar AK; Fox KAA; Parkhomenko AN; Ertl G; Störk S; Keltai M; Ryden L; Pogosova N; Dans AL; Lanas F; Commerford PJ; Torp-Pedersen C; Guzik TJ; Verhamme PB; Vinereanu D; Kim JH; Tonkin AM; Lewis BS; Felix C; Yusoff K; Steg PG; Metsarinne KP; Cook Bruns N; Misselwitz F; Chen E; Leong D; Yusuf S;
    N Engl J Med; 2017 Oct; 377(14):1319-1330. PubMed ID: 28844192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention of antithrombotic therapy in patients with stable cardiovascular disease at high ischemic risk: A network meta-analysis of randomized controlled trials.
    Zhu H; Xu X; Wang H; Chen Q; Fang X; Zheng J; Gao B; Tong G; Zhou L; Chen T; Huang J
    Front Cardiovasc Med; 2022; 9():1040473. PubMed ID: 36698936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis.
    Li M; Yang Q; Shi J; Zhang X; Lin H; Ge F
    BMC Neurol; 2023 Aug; 23(1):303. PubMed ID: 37580668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials.
    Anand SS; Hiatt W; Dyal L; Bauersachs R; Berkowitz SD; Branch KRH; Debus S; Fox KAA; Liang Y; Muehlhofer E; Nehler M; Haskell LP; Patel M; Szarek M; Yusuf S; Eikelboom J; Bonaca MP
    Eur J Prev Cardiol; 2022 May; 29(5):e181-e189. PubMed ID: 34463737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis.
    Lun R; Dhaliwal S; Zitikyte G; Roy DC; Hutton B; Dowlatshahi D
    JAMA Neurol; 2022 Feb; 79(2):141-148. PubMed ID: 34870698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD.
    Rymer J; Anand SS; Sebastian Debus E; Haskell LP; Hess CN; Jones WS; Muehlhofer E; Berkowitz SD; Bauersachs RM; Bonaca MP; Patel MR
    Circulation; 2023 Dec; 148(24):1919-1928. PubMed ID: 37850397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination anticoagulant or P2Y12 inhibitor with low-dose aspirin versus low-dose aspirin alone in patients at risk or with documented coronary and/or peripheral artery disease.
    Coleman CI; Kharat AA; Bookhart B; Baker WL
    Curr Med Res Opin; 2022 Jan; 38(1):27-34. PubMed ID: 34641745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of rivaroxaban and ticagrelor in elderly patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Liu X; Wang L; Zhou M; Feng L
    Contemp Clin Trials; 2021 May; 104():106365. PubMed ID: 33746024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticagrelor vs Clopidogrel in Acute Myocardial Infarction Patients With a History of Ischemic Stroke.
    Huang HY; Wang CC; Katz AJ; Lin SY; Lin FJ; Wu CH
    Mayo Clin Proc; 2023 Nov; 98(11):1602-1612. PubMed ID: 37923519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
    Steg PG; Bhatt DL; Simon T; Fox K; Mehta SR; Harrington RA; Held C; Andersson M; Himmelmann A; Ridderstråle W; Leonsson-Zachrisson M; Liu Y; Opolski G; Zateyshchikov D; Ge J; Nicolau JC; Corbalán R; Cornel JH; Widimský P; Leiter LA;
    N Engl J Med; 2019 Oct; 381(14):1309-1320. PubMed ID: 31475798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Connolly SJ; Eikelboom JW; Bosch J; Dagenais G; Dyal L; Lanas F; Metsarinne K; O'Donnell M; Dans AL; Ha JW; Parkhomenko AN; Avezum AA; Lonn E; Lisheng L; Torp-Pedersen C; Widimsky P; Maggioni AP; Felix C; Keltai K; Hori M; Yusoff K; Guzik TJ; Bhatt DL; Branch KRH; Cook Bruns N; Berkowitz SD; Anand SS; Varigos JD; Fox KAA; Yusuf S;
    Lancet; 2018 Jan; 391(10117):205-218. PubMed ID: 29132879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.